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Abstract
Background: This study evaluated an automated inverse treatment planning algorithm, Pinnacle Auto-Planning
(AP), and compared automatically generated plans with historical plans in a large cohort of head and neck cancer
patients.
Methods: Fifty consecutive patients treated with volumetric modulated arc therapy (Eclipse, Varian Medical System,
Palo Alto, CA) for head and neck were re-planned with AP version 9.10. Only one single cycle of plan optimization
using one single template was allowed for AP. The dose to the planning target volumes (PTV’s; 3–4 dose levels), the
organs at risk (OAR’s) and the effective working time for planning was evaluated. Additionally, two experienced
radiation oncologists blind-reviewed and ranked 10 plans.
Results: Dose coverage and dose homogeneity of the PTV were significantly improved with AP, however manually
optimized plans showed significantly improved dose conformity. The mean dose to the parotid glands, oral
mucosa, swallowing muscles, dorsal neck tissue and maximal dose to the spinal cord were significantly reduced
with AP. In 64 % of the plans, the mean dose to any OAR (spinal cord excluded) was reduced by >20 % with AP in
comparison to the manually optimized plans. In 12 % of the plans, the manually optimized plans showed reduced
doses by >20 % in at least one OAR. The experienced radiation oncologists preferred the AP plan and the clinical
plan in 80 and 20 % of the cases, respectively. The average effective working time was 3.8 min ± 1.1 min in
comparison to 48.5 min ± 6.0 min using AP compared to the manually optimized plans, respectively.
Conclusion: The evaluated automated planning algorithm achieved highly consistent and significantly improved
treatment plans with potentially clinically relevant OAR sparing by >20 % in 64 % of the cases. The effective
working time was substantially reduced with Auto-Planning.
Keywords: Volumetric modulated arc therapy, Head and neck, Automated planning optimization
Introduction
Intensity modulated radiotherapy (IMRT) and volumet-
ric modulated radiotherapy (VMAT) have been used for
more than a decade and are now standard techniques
for external beam radiotherapy treatment (RT). How-
ever, the inverse and computer-based planning approach
involves multiple manual steps, which might influence
the plan quality and consistency: planning objectives and
constraints need to be manually adapted to the patient
individual anatomy and tumor location, size and shape
[1]. Additional help structures are frequently defined to
further individualize and optimize the treatment plan on
a patient individual basis resulting in an iterative process
of IMRT and VMAT plan generation. Furthermore, the
TPS operator needs to have profound knowledge and
experience about the limitations of the treatment plan-
ning system and techniques, translating this into a pre-
diction of the dose distribution, which can be achieved
in each individual case. This method of manual
optimization is time consuming, especially for complex
cases such as head and neck carcinoma where multiple* Correspondence: Jerome.krayenbuehl@usz.ch1Department of Radiation Oncology, University Hospital Zurich, Klinik für
Radio-Onkologie, Rämistrasse 100, CH-8091 Zürich, Switzerland
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target dose levels are defined in close proximity to
OAR’s.
In order to improve the overall plan quality and
consistency, and to decrease the time required for plan-
ning, semi-automated planning algorithms have been de-
veloped [2, 3]. In the present study, we have evaluated a
fully automated treatment planning system (TPS),
Pinnacle Auto-Planning (Philips Radiation Oncology
Systems), which uses an iterative algorithm based ap-
proach to automatically adapt objectives, constraints and
dose shaping contours during the optimization process
to achieve clinical goals. It was the aim of this study to
evaluate Auto-Planning in a large cohort of head and
neck cancer patients: treatment plans were compared
with historical, clinically accepted VMAT treatment
plans generated by Eclipse RapidArc planning (Varian
Medical System, Palo Alto, CA). Additionally, time re-
quired for manual vs. Auto-Planning was compared.
Methods and materials
Automatic VMAT optimization
A new optimizer, Auto-Planning, was introduced in ver-
sion 9.10 with the Pinnacle TPS (Philips Radiation
Oncology Systems, Fitchburg, WI). It is a fully integrated
module in the TPS, similar to the “manual” inverse
optimizer module. Auto-Planning employs an iterative
algorithm approach to reach and potentially surpass user
defined clinical goals. During Auto-Planning, individual
optimization goals, constraints and weights are automat-
ically added and adjusted. The IMRT/VMAT optimizer
is automatically run multiple times with adjustments be-
ing made during and between optimization runs. Add-
itionally, Auto-Planning adjusts the priority of clinical
goals based on their probability of being achieved.
Therefore, Auto-Planning tries to mimic the decision
making process of an experienced TPS operator. In
addition to clinical objectives and priorities, Auto-
Planning has a compromise setting to allow for sparing
of serial organs such as the spinal cord over targets, and
advanced settings allow the user to set global parameters
such as priorities between targets and OAR’s, dose fall-
off, maximum dose and cold spot management.
Ethics approval and patient selection
All patients included into this study have given their ap-
proval to use their data for scientific research.
For this retrospective treatment planning study, 50
consecutive patients with diagnosis of primary meso-
pharynx, hypopharynx, oropharynx or larynx carcinoma
patients treated in our department were enrolled. Each
patient was treated with at least three dose levels: 70Gy
or 69.63Gy, 60Gy and 54Gy within 35 or 33 fractions
using a simultaneous integrated boost concept. Dose
levels of 66Gy and 52Gy were additionally defined for
six and 11 patients, respectively. The dose was normal-
ized to the mean target dose of the highest-order plan-
ning target volume (PTV). The following critical
structures were analyzed: parotids, spinal cord, brain
stem, mandibular bones, oral mucosa, pharynx, dorsal
neck tissue.
All patients were treated with the VMAT technique
using two 360°- arcs. Manual VMAT treatment planning
was performed using RapidArc planning in Eclipse treat-
ment planning version 11.0.42. The treated plans were
manually optimized for a 6-MV photon linear acceler-
ator (Trilogy, TrueBeam or Edge; Varian Medical
Systems). Clinically accepted and delivered treatment
plans served as reference in this study. All plans were
generated by experienced dosimetrists according to writ-
ten protocols. All treatment plans were verified by a
medical physicist and two radiation oncologist physicians
before treatment for all cases.
Retrospective planning study using Auto-Planning
Plans optimized with Auto-Planning utilized a single
model where clinical objectives and priorities for each
PTV and OAR are defined. The constraints for the tar-
get consist of a maximum dose allowed and a dose level
to be achieved which corresponds to the dose to 98 % of
the target volume. The clinical objectives for an OAR in-
clude dose-volume histogram, maximum dose and mean
dose. Four priority levels can be defined for the OAR:
low, medium, high or constrain. Depending on the
patient-individual overlap of the OAR with the targets,
the priority can be automatically adjusted from high to
medium (>25 % overlapping), or to low (>50 % overlap-
ping). It is possible for the user to over-ride automatic
adjustment of individual priorities, but this is outside the
scope of this investigation. In addition to priority, there
is an additional compromise setting, which allows for
individual OAR priority over targets (such as for spinal
cord).
A model (pre-set of Auto-planning preferences and
target & OAR objectives) for head and neck planning
was created in Auto-Planning based on five head and
neck cases. These five cases were not included in the set
of patients used for the plan comparison. The Auto-
Planning model was optimized by adjusting the clinical
objectives and priorities until all five plans satisfied clin-
ical target and organ at risk goals. All study plans were
then optimized with the same model. The beam geom-
etry for Auto-Planning was similar to the clinical plans
using two 360°-arcs with collimator set to 5° and 355°.
Ninety control points per arc were set for the Auto-
Planning plans and 177 for the clinical plans. The ability
to make individual adjustments to the model prior to
running Auto-Planning was limited to the target doses
in this study and was not allowed for OARs.
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One treatment plan was generated for each patient
using Auto-planning and only one optimization cycle
was allowed. This plan was used for comparison with
historical treatment plans.
Quality assurance for each clinical plan and for ten
Auto-Planning plans was performed on a phantom
(Delta4, ScandiDos AB, Uppsala, Sweden). All fields had
to have a gamma value > 95 % with a distance to agree-
ment of 3 mm and a dose difference of 3 %.
Plan comparison
Dose–volume histograms (DVHs) were calculated for
the PTVs and OARs for each plan. For comparison pur-
poses, DVHs were normalized to the mean dose of the
high dose PTV (70Gy or 69.63Gy over 35 or 33 frac-
tions). Target dose distribution was evaluated according
to the Paddick conformity index (CI) [4], the target
coverage defined as the volume enclosed by the 95 %
isodose line and the dose homogeneity index (HI) [1] de-
fined as the ratio between the dose covering 5 % of the
PTV volume to the dose covering 95 % of the PTV
volume.
The dose to OARs was evaluated according to the
mean dose for all OARs except for the spinal cord,
where the maximum dose to 0.1 cm3 was evaluated.
In addition to DVH parameters evaluation, two experi-
enced radiation oncologists blind-reviewed and ranked
10 randomized plans. They had to choose which plan
they preferred.
Planning time
The working time required by one highly experienced
dosimetrist to generate a plan was measured for the last
ten head and neck patients treated in our department.
The time was measured for the manual optimized plans
and for Auto-Planning. The planning time was defined
as the effective working time required between the point
where the target and OAR volumes are defined by the
clinicians to the time were the plans is accepted by re-
sponsible clinicians. This included the time needed for
the definition of the help structures and to re-adjust the
constraints and help structures after each optimization.
The time required for the optimization was not mea-
sured as it depends strongly on the number of plans
running in parallel on the server.
Statistics
Statistical analysis was performed using a paired t test. A
p value of <0.05 was accepted as significant.
Results
OAR objectives and priorities used for Auto-Planning
are listed in Table 1. These settings were used for the
optimization of all head-and-neck cases planned with
Auto-Planning. No individualization was performed.
Target volumes
The average DVH parameters for the clinical and Auto-
Planning plans for targets and OARs are shown in
Table 2. The plans were normalized to the mean dose of
the high dose PTV. Differences in dose homogeneity
(HI) reached significance only for PTV 70Gy: HI was
1.066 ± 0.015 for Auto-Planning and 1.091 ± 0.017 for
the clinical plans (p < 0.001). For PTV 60Gy and PTV
54Gy, HI was 1.098 ± 0.028 and 1.107 ± 0.018 for the
Auto-planning plans and 1.103 ± 0.025 and 1.106 ± 0.021
for the clinical plans, p = 0.06 and p = 0.28.
The target coverage was significantly improved with
Auto-Planning by 2.9, 3.0 and 1.3 % for the PTV 70Gy,
PTV 60Gy and PTV 54Gy (p < 0.01). However, the CI
decreased significantly with Auto-Planning (p < 0.001)
for the PTV 70Gy and for the PTV from 0.93 to 0.86
and from 0.68 to 0.64.
Organs at risk
Comparison of OAR sparing is summarized in Table 2.
Both Auto-Planning and clinical plans were able to keep
the maximum spinal cord dose below our tolerance of
45Gy for each patient. Auto-Planning further reduced
the maximal dose to the spinal cord by 1.6Gy in com-
parison to the clinical plans (p < 0.01).
The mean doses to the ipsilateral and contralateral
parotid were reduced with Auto-Planning by 1.9Gy and
2.0Gy respectively (p < 0.01), see Table 2. The largest re-
duction of the mean parotid dose with Auto-Planning
Table 1 Dose objectives used in Auto-Planning for the
optimization of head and neck plans
Constraint Priority
Myelon Dmax < 43Gy Medium
Brainstem Dmax < 48Gy Medium
Parotid Mean dose < 22Gy High
Parotid Mean dose < 15Gy Medium
Oral mucosa Mean dose < 20Gy High
Oral mucosa Mean dose < 12Gy Low
Pharynx Dmax < 45Gy Medium
Pharynx Mean dose < 20Gy High
Pharynx Mean dose < 15Gy Medium
Plexus Dmax < 61Gy Medium
Mandibular bones Dmax < 60Gy Medium
Mandibular bones Mean dose < 22Gy Medium
Brain Dmax < 48Gy Medium
Brain Mean dose < 20Gy Medium
Dorsal neck tissue Mean dose < 25Gy Medium
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was observed for clinical plans having a mean parotid
dose between 17Gy and 27Gy, see Fig. 1. In contrast, the
parotid mean dose increased on average with Auto-
Planning when the mean parotid dose was below 15Gy
or above 35Gy for the clinical plans. The parotid mean
dose was reduced by more than 10 and 20 % with Auto-
Planning in 49 and 19 % of the cases, respectively.
Contrarily, the parotid mean dose was increased with
Auto-Planning by 10 and 20 % in 11 and 2 % of the
cases, respectively (Table 3).
The mean dose to the swallowing muscles, oral mucosa,
mandibular bones and dorsal neck tissue was significantly
reduced with Auto-Planning by 3.1Gy, 1.7Gy, 3.3Gy and
3.4Gy (p < 0.01), respectively (see Table 2, Figs. 2 and 3). In
ten, seven, four and ten cases the mean dose to the swal-
lowing muscles, oral mucosa, mandibular bones and dorsal
Table 2 Dose-volume histogram parameters: comparison of clinical and Auto-Planning plans
Clinical plan AutoPlanning t-test
Mean StDev Mean StDev
Conformity index (PTV 70 Gy) 0.93 0.08 0.86 0.07 <0.01
Conformity index (PTV 54 Gy) 0.68 0.04 0.64 0.04 <0.01
Homogeneity index (PTV 70 Gy) 1.091 0.017 1.066 0.015 <0.01
Homogeneity index (PTV 60 Gy) 1.103 0.025 1.098 0.028 0.055
Homogeneity index (PTV 54 Gy) 1.106 0.021 1.107 0.018 0.279
Target coverage (PTV70Gy) 94.9 2.7 97.8 1.7 <0.01
Target coverage (PTV60Gy) 94.2 3.1 97.2 2.3 <0.01
Target coverage (PTV54Gy 93.9 3.0 95.2 2.7 <0.01
Myelon maximal dose (Gy) 42.7 3.6 41.1 2.6 <0.01
Mean ipsilat. parotid dose (Gy) 26.8 7.1 24.9 8.8 <0.01
Mean contralat. parotid dose (Gy) 21.4 5.3 19.4 5.9 <0.01
Mean swallowing muscles dose (Gy) 33.5 8.7 30.4 7.7 <0.01
Mean oral mucosa dose (Gy) 29.2 5.2 27.5 6.0 <0.01
Mean mandibular bones dose (Gy) 34.9 4.4 31.6 6.1 <0.01
Mean dorsal neck tissue dose (Gy) 28.2 5.0 24.8 3.7 <0.01
Abbreviations: PTV planning target volume
Fig. 1 Mean parotid dose difference as a function of the clinical mean parotid dose. If the values are positive, Auto-Planning reduced the parotid
mean dose. If the values are negative, the parotid mean dose was reduced with the clinical plan
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neck tissue was reduced by more than 20 % with Auto-
Planning, see Table 3. In contrast, the clinical plans showed
lower mean doses to the swallowing muscles by >20 % in
one case and for the dorsal neck tissue in three cases.
In 32 plans (64 %), Auto-Planning was able to reduce
at least one OAR (spinal cord excluded) by more than
20 %. In contrast, the clinical plans showed reduced
doses to at least one OAR by more than 20 % in six
cases (12 %), see Table 3.
The results from the blind ranking performed by two
experienced radiation oncologists showed that Auto-
Planning plans were preferred in 80 % of the cases and
in 20 % of the cases, the clinical plans were preferred.
Planning time
The effective working time required after volume definition
by the clinicians to the end of the optimization, when the
plan is ready to be checked by the clinicians, was measured
for the last ten patients planned. 3.8 min ± 1.1 min ranging
from 2.45 to 6.33 min were required for Auto-Planning
compared to 48.5 min ± 6.0 min for the clinical plans ran-
ging from 42.0 to 56.5 min.
Discussion
In this comparative study, plans manually optimized
with Eclipse were compared to plans automatically opti-
mized with Pinnacle. Both systems are using different
optimizer algorithms which potentially influence change
the results. Nevertheless, planning challenges involving
experienced operators have shown that both systems
were able to achieve similar dose distribution [5, 6].
Therefore, we do not believe that the results are biased
due to the use of two different optimization algorithms.
Results of our study show that Pinnacle Auto-
Planning, an automated iterative planning algorithm,
achieved highly consistent treatment plans: target
Table 3 Dose difference between the clinical and the Auto-Planning plans
10% - 20% lower dose with AutoPlanning 10% - 20% lower dose with the clinical plan
>20% lower dose with AutoPlanning >20% lower dose with the clinical plan
Patient number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Mean ipsilat. parotid dose
Mean contralat. parotid dose 
Myelon maximal dose
Mean oral mucosa dose
Mean swallowing muscles dose
Mean mandibular bone dose
Mean dorsal tissue dose
Each column represents the results for a patient. In light green, respectively dark green, Auto-Planning reduced the organ dose by more than 10 %, respectively
20 % in comparison to the clinical plan. In pink, respectively red, the clinical plan reduced the organ dose by more than 10 %, respectively 20 % in comparison
to Auto-Planning
Fig. 2 Mean swallowing muscles dose difference as a function of the clinical mean swallowing muscles dose. If the values are positive, Auto-Planning had
a better dose sparing of the swallowing muscles. If the values are negative, the clinical plan had a better dose sparing of the swallowing muscles
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coverage and homogeneity were significantly improved
at the expense of dose conformity compared to clinically
accepted historical plans. However, dose differences for
all target volumes were small and are unlikely to be clin-
ically relevant. Additionally, Auto-planning achieved a
significant reduction of all OAR dose. Most importantly,
Auto-Planning was able to reduce the dose to at least
one OAR by more than 20 % in 64 % of the cases.
This finding of improved OAR sparing by a potentially
clinically relevant amount could be explained by sub-
optimal constraints being used in the historical manual
planning cohort. Plan optimization for head and neck is
one of the most complex scenarios due to the complex-
ity of the tumor shape, dose levels and location. Targets
with multiple dose levels are defined in close proximity
to or as overlapping OARs making the optimization a
complex and time consuming process. The result will
strongly depend on the skill set of the TPS Operator
when setting the correct help structures, optimization
objectives and constraints.
In 19 % of the plans, the mean dose to one of the pa-
rotids was reduced by more than 20 % with Auto-
Planning. This reduction of the mean dose is expected
to be clinically relevant and reduce xerostomia [7]. The
normal tissue complication probability for the parotid
glands reported by Eisbruch et al. is described as a con-
tinuous and monotonously increasing function of the
mean dose with a steep gradient between 20Gy and
30Gy [8]. Any significant reduction of the mean dose in
this range may thus be of clinical benefit. The mean par-
otid dose increased with Auto-Planning for clinical plans
having a dose larger than 35Gy. For these cases, the tar-
gets were largely overlapping with the parotid. If this
overlap is larger than 25 and 50 %, the priority was auto-
matically reduced to medium or low with Auto-
Planning. This could explain the higher mean parotid
dose with Auto-Planning in cases where a mean dose
greater than 35Gy was observed.
A significant correlation between the mean swallowing
muscle dose and complications such as dysphagia has
been observed [9]. A steep dose-effect relationship, with
an increase of the probability of dysphagia of 19 % with
every additional 10Gy, was established [10]. We ob-
served that Auto-Planning could be clinically beneficial
for patients in respect to the dose delivered to the swal-
lowing muscles. Indeed, in 20 % of the cases, Auto-
Planning was able to reduce the swallowing muscles
mean dose by more than 20 % which correspond to a
dose reduction of 10.7Gy.
Highly consistent and improved plan quality in a rele-
vant proportion of the cases compared to our historical
plans was not only observed in DVH parameters. In-
deed, radiation oncologists specialized in head and neck
cancer preferred Auto-Planning plans compared to the
clinical plans in 80 % of the cases; however they simul-
taneously stated that results were close and both plan-
ning methods achieved clinically acceptable plans in all
patients. This result is even more surprising as only one
single Auto-Planning head and neck model—pre-set of
optimization parameters—was used in Auto-planning
and only one single optimization cycle was allowed. One
could therefore speculate that further optimization of
Fig. 3 Mean oral mucosa dose difference as a function of the clinical mean oral mucosa dose. If the values are positive, Auto-Planning had a better dose
sparing of the s oral mucosa. If the values are negative, the clinical plan had a better dose sparing of the oral mucosa
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the Auto-Planning approach might be possible by 1)
more customized optimization models and by 2) the use
of more than one optimization cycle. By increasing the
number of optimization cycles, the planner would be
able to change the targets and/or OARs objectives in
order to modify the dose distribution previously calcu-
lated. This would lead to a more patient specific dose dis-
tribution. Further analyses are ongoing to test these
hypotheses. Besides potentially improved outcome on a
patient-individual level and on an institutional level, such
automated planning approaches are considered to be es-
pecially useful within the context of multi-center trials to
standardize and homogenize planning and plan quality.
Other automated planning approaches have been dis-
cussed elsewhere [9, 10]. One method is based on a pre-
viously generated site-specific plan library: the individual
patient is compared to the patient population in library
of plans and similarity measures are used for selection of
planning optimization parameters [2, 9, 11]. This com-
pares patient-individual DVH parameters to the database
and estimates plan quality in comparison to an overall
patient population. However, the application of the li-
brary is restricted to patients with identical or very simi-
lar planning objectives (number of fractions, target and
OAR doses) [9]. Also, a larger number of plans are re-
quired for de-novo generation a robust library, which is
challenging for smaller institutions and/or rare indica-
tions. Finally, since the knowledge of the previous plans
is used to generate the objectives, the newly generated
plan quality inevitably depends on the quality of the
plans building the database [11]. Non-optimal plans en-
tered in the database may degrade results with the plan
library approach.
Multicriteria optimization (MCO) approaches [6–8]
have been proposed for real-time assessment of the
trade-off between different clinical goals. MCO allows to
navigate towards a Pareto optimal plan in a database of
automatically generated plans and thereby balance be-
tween targets and between organs at risk. One limitation
of the MCO approach is the increased time to create the
library of treatment plans before dose evaluation can be
performed, although this can be overcome by faster dose
calculations [12]. The MCO approach also requires sig-
nificant individual user experience and interaction to de-
termine the Pareto optimal plan, which may become
especially challenging in head and neck cases were mul-
tiple targets and organs at risk then need to be balanced.
In addition, if the MCO generated library of plans is flu-
ence based, the Pareto optimal plan will not be deliver-
able, and further fluence segmentation is required.
Conclusion
In conclusion, our study shows that the Pinnacle Auto-
Planning approach achieves highly consistent treatment
plans for complex head-and-neck cancer patients: dose
distributions of the target volumes were similar between
the automated planning approach and manual planning.
OAR sparing was significantly improved using Auto-
Planning and potentially relevant improved OAR sparing
was observed in more than half of the patients. Further-
more, experienced radiation oncologists preferred the
dose distributions from Auto-Planning in comparison to
those from the manually generated plans in 80 % of the
cases. Human resources required for treatment planning
was substantially reduced and made independently from
the experience of the treatment planner.
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